# Pfam and Protein Families: How to Use Domain Annotations to Enhance Functional Interpretation of Proteomics Data

Proteomics experiments routinely identify hundreds to thousands of proteins, but a list of protein identifiers alone does not explain what those proteins do in a biological system. Pfam domain annotations provide a systematic way to group identified proteins by their functional and structural building blocks, enabling researchers to move from a flat list of accessions to testable hypotheses about pathways, molecular functions, and protein interactions. This article explains what Pfam is, how to retrieve domain annotations for a protein list, how to perform enrichment analysis, and how to visualize domain architecture, with concrete workflow decisions and quality checks appropriate for academic and clinical proteomics laboratories.

## The Problem: Protein Lists Are Not Biological Interpretations

When a mass spectrometry experiment produces a list of differentially abundant proteins, the immediate question is what those proteins mean for the system under study. A spreadsheet containing 500 UniProt accessions and fold-change values does not reveal whether the sample reflects activation of a particular signaling cascade, a shift in metabolic flux, or contamination from a common laboratory reagent. Researchers need a layer of functional annotation that connects protein identity to biological process.

Pfam addresses this need by classifying proteins into families based on conserved sequence regions known as domains. A domain is a discrete region of a protein that can fold independently, often carries a specific molecular function, and appears across many different proteins through evolutionary conservation. When you annotate a protein list with Pfam domains, you convert raw identifications into functional categories that can be counted, compared, and tested for statistical enrichment.

The practical value of this approach is well established in the bioinformatics community. The European Bioinformatics Institute provides structured training pathways for researchers who need to learn how to use protein family databases and related analysis tools, and these resources are designed for working scientists instead of computer science specialists. Similarly, the Galaxy Training Network offers accessible workflow tutorials that demonstrate how to connect sequence databases, annotation tools, and statistical tests in reproducible pipelines. For researchers who prefer command-line approaches, Bioconductor provides documented packages for genomic and proteomic analysis within the R environment, and the nf-core documentation describes standardized pipeline configurations that support reproducible analysis across different computing environments.

## What Pfam Provides and How It Relates to Other Databases

Pfam is a database of protein families, each represented by a multiple sequence alignment and a profile hidden Markov model. The profile HMM captures the conserved amino acid patterns across a family and allows sensitive detection of distant homologs that would be missed by simple pairwise sequence comparison. Each Pfam entry includes a description of the domain function, literature references, and annotations of known structures where available.

The relationship between Pfam and other resources matters for practical workflow design. InterProScan integrates Pfam with several other signature databases, including PANTHER, and produces a unified functional annotation for each query protein. The UCSC Proteome Browser, developed for human, mouse, and rat proteomes, displays Pfam domain information alongside other protein properties such as transmembrane regions, signal peptides, and isoelectric point, and links to three-dimensional structures in the Protein Data Bank. This integration means that Pfam annotations are rarely used in isolation, they feed into broader functional interpretation pipelines.

For proteomics researchers, the key distinction is between sequence-based domain annotation and structure-based annotation. Traditional Pfam annotation relies on sequence similarity, which works well for proteins with clear homologs in the database. However, structural conservation often exceeds sequence conservation, meaning that proteins with divergent sequences may still share a common fold and function. A 2024 study in NAR Genomics and Bioinformatics demonstrated that structure-based domain annotation using Foldseek could identify over 400 new domains in the Trypanosoma brucei proteome that were missed by sequence-based Pfam and Pfam-N tools. This finding has direct implications for researchers working on non-model organisms or proteins with few characterized homologs, where sequence-based annotation may underestimate the true domain content.

## At a Glance: Pfam Annotation Workflow Decisions

The table below summarizes the main workflow options for adding Pfam domain annotations to a proteomics dataset, with the key decision criteria for each approach.

| Workflow Option | Input Required | Output Produced | Best Used When |
| --- | --- | --- | --- |
| Web-based InterProScan | Protein sequences in FASTA format | Domain annotations with Pfam and other signatures | You have a modest protein list and want a visual interface with downloadable results |
| Command-line InterProScan | Protein sequences in FASTA format, local installation | Domain annotations in TSV, GFF3, or JSON formats | You need to process many samples or integrate annotation into an automated pipeline |
| Bioconductor annotation packages | UniProt accessions or Ensembl gene identifiers | Domain mappings and enrichment test results within R | You are already working in R for statistical analysis of quantitative proteomics data |
| Galaxy workflows | Protein sequences or identified peptide lists | Annotated tables and enrichment outputs with provenance tracking | You need a reproducible workflow that colleagues can rerun without command-line expertise |
| Structure-based annotation with Foldseek | Predicted protein structures | Domain annotations based on structural similarity | You study non-model organisms or proteins with low sequence conservation to known families |

## Core Principles of Domain-Based Functional Interpretation

### Domains Are the Functional Units of Proteins

Proteins are modular assemblies of domains, and each domain typically contributes a specific function such as binding a ligand, catalyzing a reaction, or mediating protein-protein interaction. This modularity means that two proteins sharing a particular domain are likely to share the molecular function associated with that domain, even if their overall sequences are otherwise dissimilar. When you annotate a proteomics dataset with Pfam domains, you are effectively asking which molecular building blocks are present in your sample and whether any are overrepresented relative to what you would expect by chance.

The evolutionary perspective strengthens this interpretation. A 2023 study in Molecular Biology and Evolution examined the retention patterns of Pfam domains across animal evolution and found that domains with intermediate levels of structural disorder and hydrophobic clustering are retained at the highest rates. Domains with extreme values of these properties are lost more frequently over evolutionary time. This finding suggests that the set of Pfam domains present in a proteome reflects long-term selection on domain properties, and that domain-based comparisons across species or conditions can reveal meaningful biological differences instead of random noise.

### Sequence-Based Annotation Has Known Limits

The accuracy of Pfam annotation depends on the sensitivity of the profile HMM and the completeness of the underlying sequence database. For well-characterized proteins from model organisms, sequence-based annotation is highly reliable. For proteins from phylogenetically distant species, or for proteins with unusual amino acid composition, sequence-based methods may miss domains that are present at the structural level.

The 2024 structural annotation study illustrates this limitation clearly. The authors created a database of Pfam seed domains segmented at their domain boundaries, then aligned the predicted structures of the T. brucei proteome against this database using Foldseek. This approach identified more than 400 domains that sequence-based Pfam annotation had missed, and manual validation confirmed several of these predictions. The practical implication is that researchers working on non-model organisms should consider supplementing sequence-based Pfam annotation with structure-based methods, particularly when their proteins of interest have few characterized homologs.

### Predicted Structures Can Support Domain Mapping

The availability of high-quality predicted protein structures has changed how researchers can approach domain annotation. AlphaFold2 and ESMFold both produce predicted structures for protein sequences, and these predictions can be used to map Pfam domains onto the three-dimensional fold. A 2025 study in Computational and Structural Biotechnology Journal compared AlphaFold2 and ESMFold models for the human reference proteome and found that regions overlapping Pfam domains had high local confidence scores with both methods. The study mapped 9,834 Pfam domains and located 2,578 active sites in 3,382 human enzymes, including 807 proteins for which the active site was not reported in UniProt.

This result has two practical implications for proteomics researchers. First, predicted structures can confirm and refine domain boundaries, which is useful when you need to design experiments targeting a specific functional region. Second, the ability to locate active sites in proteins without UniProt annotations means that structure-guided domain mapping can reveal functions that would otherwise be missed. The study also noted that AlphaFold2 produced slightly higher confidence scores in Pfam-containing regions than ESMFold, which may matter if you are choosing between prediction methods for a critical protein.

## Practical Workflow: From Protein List to Domain Annotations

### Step 1: Prepare Your Input Data

The starting point for Pfam annotation is a list of protein sequences in FASTA format. If your proteomics software has already mapped peptides to proteins, you will typically have a protein group table with accession numbers. You need to retrieve the full-length protein sequences for those accessions from a sequence database such as NCBI or UniProt. The NCBI data resources provide search systems and sequence retrieval tools that support batch downloads, and the European Bioinformatics Institute offers training materials on how to use these resources effectively.

For most workflows, you should use the canonical or reference sequence for each protein accession. If your proteomics analysis used a custom database that includes isoforms or variants, you need to decide whether to annotate each isoform separately or use a representative sequence. Annotating all isoforms can inflate the number of domain hits if the isoforms share most of their sequence, so a representative sequence per gene is usually the more interpretable choice.

### Step 2: Choose Your Annotation Tool

The choice of annotation tool depends on your dataset size, your computing environment, and your need for reproducibility. For a single protein list of a few hundred sequences, the web-based InterProScan interface is straightforward and requires no local installation. You upload your FASTA file, select the databases you want to search, and download the results when the search completes.

For larger datasets or repeated analyses, a local installation of InterProScan gives you more control and avoids the practical limits of web submission. The command-line version produces structured output formats that are easy to parse with scripting languages, and it can be integrated into automated pipelines. The nf-core documentation describes how community pipelines handle annotation steps in reproducible workflow environments, which is useful if you are building a pipeline that other members of your group will run.

If you are working in R for your statistical analysis, Bioconductor packages provide programmatic access to domain annotations and enrichment tests. This approach keeps your entire analysis in one environment and makes it easier to document your workflow. The Bioconductor project maintains installation and usage documentation for all packages, and the training materials cover common analysis patterns.

### Step 3: Run the Annotation and Parse the Results

InterProScan produces several output formats, including TSV, GFF3, and JSON. The TSV format is the most convenient for downstream analysis in spreadsheet software or R. Each row represents one match between a query protein and a database signature, and the columns include the query identifier, the database name, the signature accession, the signature description, and the start and end positions of the match within the query sequence.

When you parse the results, you need to decide how to handle multiple matches for the same protein. A single protein can contain several different domains, and each domain will appear as a separate row. For enrichment analysis, you typically count each domain once per protein, even if the protein contains multiple copies of the same domain. This avoids inflating the count for proteins with repeated domains.

### Step 4: Map Domains to Functional Categories

Pfam domains are associated with functional descriptions, but these descriptions are not always directly interpretable in terms of biological processes. To connect domains to pathways and processes, you may need to use additional annotation layers. InterProScan results include Gene Ontology terms that are associated with each signature, and these terms can be used for GO enrichment analysis. The PANTHER database, which is included in InterProScan, provides pathway annotations that link proteins to curated signaling and metabolic pathways.

The FastProtein pipeline, described in a 2024 PeerJ publication, integrates multiple annotation sources including InterProScan, PANTHER, and Pfam, and produces outputs for subcellular location, transmembrane domains, signal peptides, molecular weight, isoelectric point, and other protein properties. This tool is designed to streamline proteomics analysis by producing multiple results in a single step, and it is available as open-source software with installation instructions on GitHub. For researchers who want a comprehensive annotation without writing custom scripts, this type of integrated tool can save substantial time.

### Step 5: Perform Enrichment Analysis

Enrichment analysis asks whether particular domains appear more frequently in your protein list than would be expected by chance, given the background distribution of domains in the proteome. The choice of background is critical. For a whole-proteome experiment, the background should be all proteins that were detectable in your sample, not all proteins in the organism. Using the entire proteome as background can produce false enrichment signals if your detection method is biased toward abundant or easily ionized proteins.

Several tools perform enrichment analysis on domain annotations. The Bioconductor ecosystem includes packages that test for overrepresentation of functional categories, and these can be applied to Pfam domain counts. The Galaxy Training Network provides tutorials that demonstrate enrichment workflows with reproducible parameters. When you run an enrichment test, you need to set a significance threshold and correct for multiple testing, because you will typically test hundreds of domains simultaneously.

### Step 6: Visualize Domain Architecture

Domain architecture visualization shows the arrangement of domains along each protein sequence, which can reveal functional relationships that are not apparent from a list of domain counts. For example, a protein with a kinase domain adjacent to a protein-protein interaction domain is likely to function in signal transduction, while a protein with multiple DNA-binding domains may be a transcriptional regulator.

The UCSC Proteome Browser provides graphical displays of protein properties including Pfam domains, and it links to three-dimensional structures and pathway databases. For custom visualization of your own protein list, you can generate domain architecture diagrams using R packages or Python libraries that read InterProScan GFF3 output. These diagrams are particularly useful for presentations and publications because they communicate the modular structure of proteins at a glance.

## Options and Tradeoffs in Annotation Strategy

### Web-Based versus Local Annotation

Web-based annotation through the InterProScan website is the simplest option for small datasets. You do not need to install software or manage dependencies, and the results are presented in a user-friendly interface. The tradeoff is that you are limited by upload size and processing time, and you may need to wait for your job to complete in a queue.

Local annotation gives you full control over the process and is necessary for large datasets or sensitive data that cannot be uploaded to an external server. The cost is the time required to install and configure the software, which can be substantial if you are working in a restricted computing environment. The nf-core documentation provides guidance on configuring pipelines in different environments, which can help you avoid common installation problems.

### Sequence-Based versus Structure-Based Annotation

Sequence-based annotation is the default for most proteomics analyses because it is fast, well documented, and reliable for well-characterized proteins. Structure-based annotation is slower and requires predicted structures, but it can identify domains that sequence-based methods miss. The 2024 structural annotation study demonstrated that structure-based methods can find hundreds of additional domains in a single proteome, which suggests that sequence-based annotation alone may underestimate domain content for non-model organisms.

The choice between these approaches depends on your organism and your research question. If you are working with human or mouse proteins, sequence-based annotation is likely sufficient because these proteomes are well represented in Pfam. If you are working with a less-studied organism, you should consider running both sequence-based and structure-based annotation and comparing the results. The 2025 comparison of AlphaFold2 and ESMFold models provides a practical reference for how well predicted structures support domain mapping, and it confirms that both methods produce reliable annotations in Pfam-containing regions.

### Integrated Pipelines versus Manual Steps

Integrated pipelines such as FastProtein combine multiple annotation steps into a single run, which reduces the potential for errors in data transfer between tools. The FastProtein publication emphasizes that integrating data from different software is laborious and that the tool was designed to streamline this process. For researchers who are not comfortable with command-line scripting, an integrated tool with a web interface can make comprehensive annotation accessible.

The tradeoff is that integrated pipelines may not offer the flexibility to customize every step, and you may need to use additional tools for specialized analyses. The Galaxy Training Network provides a middle ground, offering reproducible workflows that combine multiple tools while allowing you to inspect and modify each step. This approach is particularly valuable for training new group members or for documenting your analysis for publication.

## Observations and Measurements: What to Record During Annotation

### Record Your Database Versions

Pfam and InterPro are updated regularly, and the version of the database you use affects your results. A domain that is present in version 35 may be split into two domains in version 36, or a new family may be added that changes the annotation of a previously unclassified protein. You should record the exact version of Pfam and InterProScan that you used, along with the date of the search, so that your results can be reproduced or compared with future analyses.

### Record Your Search Parameters

InterProScan has parameters that affect sensitivity and specificity, including the E-value threshold for reporting matches. The default parameters are appropriate for most analyses, but you should record any changes you make. If you lower the E-value threshold to reduce false positives, you may miss weak but genuine matches. If you raise it to increase sensitivity, you may include matches that are not statistically significant. Your choice should be documented in the methods section of any publication.

### Record Your Background Set for Enrichment

The background set for enrichment analysis is a major determinant of your results, and it must be recorded precisely. If you use all detected proteins as the background, you need to define what counts as detected, such as proteins with at least two unique peptides or proteins above a certain abundance threshold. If you use the entire proteome as the background, you need to record the source and version of the proteome database. The choice of background can change which domains appear enriched, so transparency is essential.

### Record Your Multiple Testing Correction

Enrichment analysis involves testing many domains simultaneously, and you need to correct for multiple testing to control the false discovery rate. The most common approach is the Benjamini-Hochberg procedure, which controls the expected proportion of false positives among the domains called significant. You should record the correction method and the significance threshold you used, and you should report the adjusted p-values instead of raw p-values in your results.

## Common Failure Patterns and How to Avoid Them

### Failure Pattern 1: Using the Wrong Background for Enrichment

The most common error in domain enrichment analysis is using the entire proteome as the background when your experiment only detected a subset of proteins. This error produces enrichment signals for abundant proteins that are simply more likely to be detected, not because they are biologically relevant to your condition. The fix is to use the set of all detected proteins as the background, so that you are testing whether a domain is overrepresented among your differentially abundant proteins relative to your detectable proteome.

### Failure Pattern 2: Ignoring Redundant Domains

Some proteins contain multiple copies of the same domain, and counting each copy separately can inflate the apparent importance of that domain. For example, a protein with five zinc finger domains will contribute five counts to the zinc finger domain category if you count each match. For most enrichment analyses, you should count each domain once per protein, so that the protein contributes one count regardless of how many copies of the domain it contains. This approach treats the protein as the unit of analysis, which is consistent with how you treat other protein properties.

### Failure Pattern 3: Overinterpreting Domain Presence as Activity

The presence of a domain does not guarantee that the protein is active. A kinase domain may be present but catalytically inactive due to mutations in the active site, and a DNA-binding domain may be present but unable to bind DNA because of post-translational modifications. Domain annotation tells you about the evolutionary and structural history of a protein, not necessarily its current activity in your sample. You should treat domain annotations as hypotheses to be tested experimentally, not as definitive evidence of function.

### Failure Pattern 4: Neglecting Sequence Quality

The quality of your input sequences affects the quality of your domain annotations. If your FASTA file contains truncated sequences, the domain annotation will miss domains that are located in the missing regions. If your sequences contain errors from sequencing or assembly, the profile HMM may fail to match a domain that is actually present. You should verify that your input sequences are full-length and that they correspond to the correct protein accessions before running the annotation.

### Failure Pattern 5: Failing to Document the Workflow

A common problem in proteomics bioinformatics is that the analysis workflow is not documented well enough for another researcher to reproduce it. This is particularly problematic for domain annotation because the results depend on database versions, search parameters, and background choices. The Carpentries lessons provide foundational training in reproducible computing practices, including version control with Git and documentation of analysis steps. Adopting these practices from the start of your project will save time when you need to revise your analysis or respond to reviewer requests.

## Limitations of Pfam Annotation for Proteomics Interpretation

### Coverage Gaps in Pfam

Pfam does not cover all proteins. Some proteins have no recognizable domains, either because they are intrinsically disordered or because they belong to families that have not yet been characterized. The proportion of unannotated proteins varies by organism, and it is higher for non-model organisms. When you present your enrichment results, you should report the proportion of your protein list that received at least one Pfam annotation, so that readers can judge the completeness of the analysis.

### Domain Annotation Is Not Functional Validation

A Pfam domain annotation is a computational prediction based on sequence or structural similarity. It is not experimental evidence that the protein performs the function associated with the domain. The confidence in the annotation depends on the quality of the underlying alignment and the evolutionary distance between your protein and the characterized members of the family. For critical findings, you should validate the predicted function experimentally, for example by measuring enzymatic activity or binding affinity.

### Structural Prediction Adds a Layer of Uncertainty

When you use structure-based annotation, you are relying on predicted structures that carry their own uncertainty. The 2025 comparison of AlphaFold2 and ESMFold found that both methods produced reliable predictions in Pfam-containing regions, but the confidence scores varied between methods and between proteins. You should check the predicted local distance difference test scores for the regions that contain your domains of interest, and you should be cautious about annotations that fall in low-confidence regions.

### Evolutionary Context Matters

The presence of a domain in your protein does not tell you when the domain was acquired or lost in evolutionary history. A domain that is common across all animals may have a different biological significance than a domain that is specific to your species of interest. The 2023 study on domain retention showed that domain properties such as structural disorder and hydrophobic clustering affect retention rates over evolutionary time, which means that the domain content of a proteome reflects both function and evolutionary history. When you interpret enrichment results, you should consider whether the enriched domains reflect a biological response to your experimental condition or a broader evolutionary pattern in your organism.

## Quality Controls and Professional Escalation Criteria

### Quality Control Checks Before Accepting Results

Before you accept the results of a Pfam annotation and enrichment analysis, you should perform several quality checks. First, verify that your input sequences match the expected protein accessions by checking a random sample of sequences against the source database. Second, confirm that the annotation pipeline completed without errors and that the output file contains the expected number of rows. Third, check the distribution of domain counts across your protein list to identify any proteins with an unusually large number of domains, which may indicate a problem with the sequence or the annotation. Fourth, compare your enrichment results with published literature on your system to see whether the enriched domains are consistent with known biology.

### When to Escalate to a Specialist

Some problems require expertise beyond what a typical proteomics laboratory can provide. If you are working with a non-model organism and your sequence-based annotation produces a very low coverage rate, you should consider consulting a bioinformatician who can set up structure-based annotation. If your enrichment results are unstable across different background choices, you should seek advice on the appropriate statistical approach. If you are planning to publish your results and you are uncertain about the annotation methods, you should consult the training materials from the European Bioinformatics Institute or the Galaxy Training Network, or contact a local bioinformatics core facility.

### Documentation Standards for Publication

When you publish results that depend on Pfam annotation, you should report the database version, the annotation tool and its version, the search parameters, the background set for enrichment, and the multiple testing correction method. This information allows reviewers and readers to evaluate the reliability of your analysis and to reproduce it if needed. The nf-core documentation provides examples of how pipeline parameters are reported in reproducible workflows, and the Bioconductor project maintains documentation standards for R-based analyses.

## Safety and Regulatory Context for Clinical Proteomics

### Data Handling for Patient Samples

If your proteomics data come from patient samples, you need to consider data protection and privacy requirements. Uploading sequence data to external web servers may not be permitted under your institutional review board approval or your data protection agreement. In this case, you should use a local installation of the annotation software and keep all data within your institution's computing environment. The nf-core documentation provides guidance on configuring pipelines for secure environments, and your institutional information security office can advise on the specific requirements for your setting.

### Reproducibility for Regulatory Submission

If your proteomics analysis will be part of a regulatory submission, such as a diagnostic test validation or a clinical trial biomarker analysis, you need to document your bioinformatics workflow to a higher standard than for basic research. This includes version control of all software and databases, complete parameter records, and validation of the annotation pipeline on known positive and negative controls. The Galaxy Training Network emphasizes reproducibility as a core principle, and the Carpentries lessons provide training in version control and documentation practices that support regulatory-grade analysis.

### Interpretation Limits for Clinical Decisions

Domain annotations are computational predictions and should not be used as the sole basis for clinical decisions. If you are using proteomics data to guide patient management, you need to validate any domain-based findings with orthogonal methods, such as targeted mass spectrometry, western blotting, or functional assays. The presence or absence of a domain in a protein identified from a patient sample should be treated as a hypothesis-generating observation, not as a diagnostic result.

## Frequently Asked Questions

### What is the difference between a Pfam family and a Pfam domain?

A Pfam family is a collection of related proteins that share a common evolutionary origin, and a Pfam domain is a specific region within those proteins that has a conserved sequence and often a conserved function. A single protein can contain multiple domains, and each domain may belong to a different family. When you annotate a protein with Pfam, you are identifying which domains are present and where they are located along the sequence.

### How do I get Pfam annotations for a list of protein accessions?

You need to retrieve the protein sequences for your accessions in FASTA format, then submit those sequences to an annotation tool such as InterProScan. The web interface accepts FASTA files and returns results that include Pfam matches. For larger lists or automated workflows, you can install InterProScan locally or use Bioconductor packages within R. The European Bioinformatics Institute provides training materials that walk through the process step by step.

### What is the best background set for Pfam domain enrichment analysis?

The best background set is the set of all proteins that were detectable in your experiment, not the entire proteome of the organism. Using all detected proteins as the background controls for detection bias and tests whether a domain is overrepresented among your proteins of interest relative to what you could have detected. You should define your detection criteria clearly, such as a minimum number of unique peptides or a minimum abundance threshold, and record them in your methods.

### Can I use Pfam annotations for proteins from non-model organisms?

Yes, but you should be aware that sequence-based Pfam annotation has lower coverage for non-model organisms because the database is built from characterized proteins, which are concentrated in model organisms. Structure-based annotation using predicted structures can identify additional domains that sequence-based methods miss, as demonstrated in a 2024 study on Trypanosoma brucei. If your organism is phylogenetically distant from well-characterized species, consider running both sequence-based and structure-based annotation.

### How do AlphaFold2 and ESMFold predicted structures help with Pfam annotation?

Predicted structures provide a three-dimensional context for domain mapping. A 2025 study compared AlphaFold2 and ESMFold models for the human proteome and found that both methods produced reliable predictions in regions overlapping Pfam domains, with high local confidence scores. These predictions can confirm domain boundaries and locate active sites, including active sites that are not reported in UniProt. Structure-based annotation is particularly useful for proteins with low sequence conservation to known families.

### What output format should I use from InterProScan?

The TSV format is the most convenient for downstream analysis because it is easy to import into spreadsheet software or R. Each row represents one match between a query protein and a database signature, with columns for the query identifier, database name, signature accession, description, and match coordinates. The GFF3 format is useful for visualization in genome browsers, and the JSON format is useful for programmatic access. Choose the format that matches your downstream analysis tools.

### How do I visualize domain architecture for multiple proteins?

You can generate domain architecture diagrams from InterProScan GFF3 output using R packages or Python libraries. These diagrams show the arrangement of domains along each protein sequence, which can reveal functional relationships such as a kinase domain adjacent to a protein-protein interaction domain. The UCSC Proteome Browser provides graphical displays for human, mouse, and rat proteins, with links to structures and pathway databases.

### What should I report in my publication about Pfam annotation?

You should report the Pfam database version, the annotation tool and its version, the search parameters including any E-value thresholds, the background set used for enrichment analysis, and the multiple testing correction method. This information allows readers to evaluate the reliability of your analysis and to reproduce it. The nf-core documentation and Bioconductor project provide examples of how these details are documented in reproducible workflows.

## Related Bioinformatics Guides

- [Proteomics Analysis Tools: A Comparative Guide for Functional Interpretation](/knowledge/bioinformatics/proteomics-analysis-tools-a-comparative-guide-for-functional-interpretation)
- [Olink Proteomics: A Practical Guide to Panel Selection and Data Interpretation](/knowledge/bioinformatics/olink-proteomics-a-practical-guide-to-panel-selection-and-data-interpretation)
- [Functional Annotation of Metagenomes: A Guide to Databases and Pipelines](/knowledge/bioinformatics/functional-annotation-of-metagenomes-a-guide-to-databases-and-pipelines)
- [Lipidomic Analysis: A Beginner's Guide to Workflows and Data Interpretation](/knowledge/bioinformatics/lipidomic-analysis-a-beginner-s-guide-to-workflows-and-data-interpretation)
- [Pathway Enrichment Analysis for Proteomics: Tools and Interpretation](/knowledge/bioinformatics/pathway-enrichment-analysis-for-proteomics-tools-and-interpretation)

## References and Further Reading

- [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/). National Center for Biotechnology Information.
- [EMBL-EBI Training](https://www.ebi.ac.uk/training). European Bioinformatics Institute.
- [Bioconductor](https://bioconductor.org/). Bioconductor Project.
- [Galaxy Training Network](https://training.galaxyproject.org/). Galaxy Project.
- [nf-core Documentation](https://nf-co.re/docs). nf-core.
- [The Carpentries Lessons](https://carpentries.org/lessons). The Carpentries.
- [Functional domain annotation by structural similarity.](https://pubmed.ncbi.nlm.nih.gov/38298181). NAR genomics and bioinformatics, 2024.
- [AlphaFold2 and ESMFold: A large-scale pairwise model comparison of human enzymes upon Pfam functional annotation.](https://pubmed.ncbi.nlm.nih.gov/39916697). Computational and structural biotechnology journal, 2025.
- [FastProtein-an automated software for in silico proteomic analysis.](https://pubmed.ncbi.nlm.nih.gov/39494269). PeerJ, 2024.
- [The UCSC Proteome Browser.](https://pubmed.ncbi.nlm.nih.gov/15608236). Nucleic acids research, 2005.
- [Differential Retention of Pfam Domains Contributes to Long-term Evolutionary Trends.](https://pubmed.ncbi.nlm.nih.gov/36947137). Molecular biology and evolution, 2023.

> This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.